Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000187:drug effects*; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology*; D066298:In Vitro Techniques; D007741:Labetalol / Q000494:pharmacology*; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010904:Pituitary Gland, Posterior / Q000201:enzymology; D051381:Rats; D013134:Spiperone / Q000378:metabolism
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D013134:Spiperone; D000262:Adenylyl Cyclases; D007741:Labetalol; D004298:Dopamine; D009638:Norepinephrine